This report serves as a fair prototype of the Imaging Contract Research Organization (CRO) industry, offering an in-depth study of the global Imaging CRO market. It covers various industry aspects ...

Primo Biotechnology Co., Ltd. ("Primo") proudly announces that its Taoyuan pharmaceutical facility has successfully passed ...

Debiopharm and Oncodesign Services Launch Strategic Collaboration to Propel Radiopharmaceuticals in Preclinical Research April 24th, 2025 Martigny, Switzerland. Dijon, France – Debiopharm Research & ...

Analysts have set 12-month price targets for Medpace Hldgs, revealing an average target of $341.6, a high estimate of $362.00 ...

Ainos (AIMD) announced progress in advancing its oral interferon drug platform, VELDONA in the rare disease space. The Taiwan Food and Drug ...

For investors, grasping market sentiments and expectations in the industry is vital. This analysis explores the latest ...

FUJIFILM Diosynth Biotechnologies, a global contract development and manufacturing organization (CDMO) with major operations ...

Oncodesign Services has appointed Dr. Aidan Synnott as chief executive officer, to help strengthen its position as a trusted partner in drug discovery. The appointment reflects the company’s ...

ICON Public Limited Company’s ICLR share price has surged by 5.63%, which has investors questioning if this is right time to sell.

Oncodesign Services, a contract research organization specializing in drug discovery and preclinical development, appointed Dr. Aidan Synnott as chief executive officer, to help strengthen its ...

These may include statements regarding the future financial position, business strategy and strategic goals, commercial activities and timing, competitive conditions, research and development ...

A fast-evolving field where AI and robotics are beginning to redefine precision, personalization, and access to care ...